Breast cancer molecular diagnostics in Rwanda: a cost-minimization study of immunohistochemistry versus a novel GeneXpert ® mRNA expression assay.

Objective To compare the financial and time cost of breast cancer biomarker analysis by immunohistochemistry with that by the Xpert ® STRAT4 assay. Methods We estimated costs (personnel, location, consumables and indirect) and time involved in breast cancer diagnosis at the Butaro Cancer Centre of E...

Full description

Bibliographic Details
Published in:Bulletin of the World Health Organization Vol. 101; no. 1; pp. 10 - 20
Main Authors: Erfani, Parsa, Gaga, Esther, Hakizimana, Emmanuel, Kayitare, Emmanuel, Mugunga, Jean Claude, Shyirambere, Cyprien, Milner, Dan A., Shulman, Lawrence N., Ruhangaza, Deogratias, Fadelu, Temidayo
Format: research tables/charts Journal Article
Published: World Health Organization Jan2023
Online Access:View this record in EBSCOhost